Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Multifocal Motor Neuropathy: early-phase trial registry

1 of 2 indexed Multifocal Motor Neuropathy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Multifocal Motor Neuropathy: 2 US clinical trials tracked, 1 recruiting.

Multifocal Motor Neuropathy is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Dianthus Therapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition multifocal-motor-neuropathy

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Multifocal Motor Neuropa (th…50%
Open-enrollment share among volume-matched conditions near Multifocal Motor Neuropathy

Multifocal Motor Neuropathy lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Multifocal Motor Neuropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Multifocal Motor Neuropathy is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

argenx 1 trials

Named interventions

Most-linked intervention names on Multifocal Motor Neuropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

DNTH103 Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Multifocal Motor Neuropathy trials. A trial with sites in several states counts in each.

Ohio 2 trials
North Carolina 2 trials
Kansas 2 trials
Florida 2 trials
California 2 trials
Arizona 2 trials
Texas 1 trials
Oregon 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Multifocal Motor Neuropathy page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Multifocal Motor Neuropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Dianthus Therapeutics sponsors the most Multifocal Motor Neuropathy trials on record, review their full trial history before evaluating a specific study. See Dianthus Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Multifocal Motor Neuropathy condition card totals 2 registered trials; most-linked intervention DNTH103; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.